Vivaglobin and arthralgia Patient Reports February 11, 2012

Vivaglobin Side Effects Report #5253244-3
Vivaglobin side effect was reported by a Health Professional from UNITED STATES on Feb 16, 2007. Female patient, 41 years of age, weighting 123.0 lb, was diagnosed with primary immunodeficiency syndrome and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: arthralgia, breast mass, condition aggravated, dysgeusia, headache , infusion site pain, nausea . Vivaglobin dosage: unknown. Patient recovered.

Vivaglobin Side Effects Report #5706687-5
Vivaglobin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 15, 2008. Female patient, weighting 150.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: arthralgia, back pain , chest pain , chills, confusional state, disturbance in attention, fatigue, feeling abnormal, headache . Vivaglobin dosage: 8 GRAMS IN 50 ML. ONE 4 HR INFUSION SQ. During the same period patient was treated with PREDNISONE, ALTACE, ATENOLOL, ELMIRON, THYROID, ALPRAZOLAM, FOLACINCAPSULE. Patient recovered.

Vivaglobin Side Effects Report #5706688-7
Vivaglobin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 15, 2008. Female patient, weighting 150.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: arthralgia, asthma , bronchospasm, cough, fatigue, infusion related reaction, malaise, myalgia, rash macular. Vivaglobin dosage: 8 GRAMS IN 50 ML. ONE 4 HR INFUSION SQ. During the same period patient was treated with PREDNISONE, ALTACE, ATENOLOL, ELMIRON, THYROID, ALPRAZOLAM, FOCALINCAPSULE. Patient recovered.

Vivaglobin Side Effects Report #5720568-2
Vivaglobin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 28, 2008. Female patient, weighting 150.0 lb, was diagnosed with immunodeficiency common variable and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: arthralgia, asthma , blood electrolytes decreased, blood potassium decreased, blood sodium decreased, cough, electrolyte imbalance, familial risk factor, fatigue. Vivaglobin dosage: 8 GRAMS IN 50 ML. ONE 4 HR INFUSION SQ. During the same period patient was treated with ALTACE, ATENOLOL, ELMIRON, THYROID, ALPRAZOLAM, FOCALIN, CLARITHROMYCIN. Patient recovered.


Vivaglobin Side Effects Report #5356649-5
Vivaglobin side effect was reported by a Physician from UNITED STATES on June 12, 2007. Male patient, weighting 150.0 lb, was diagnosed with hypogammaglobulinaemia and was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: abasia, arthralgia, feeling cold, infusion related reaction. Vivaglobin dosage: 40 MG/L WEEKLY SUBCUT. Patient recovered.

Vivaglobin Side Effects Report #5986916-3
Vivaglobin side effect was reported by a Consumer or non-health professional from BELGIUM on Nov 14, 2008. Female patient was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: allergic respiratory symptom, arthralgia, bronchitis , fatigue, feeling cold, gastritis, gastrointestinal disorder, hepatomegaly, ill-defined disorder. Vivaglobin dosage: unknown. During the same period patient was treated with ZANTAC, SERTRALINE, EFFORTIL. Patient was hospitalized. Patient recovered.

Vivaglobin Side Effects Report #6032179-2
Vivaglobin side effect was reported by a Consumer or non-health professional from BELGIUM on Dec 19, 2008. Female patient was treated with Vivaglobin. After drug was administered, patient experienced the following side effects: arthralgia, bronchitis , fatigue, hepatomegaly, hypersensitivity, influenza, infusion related reaction, joint swelling, malaise. Vivaglobin dosage: unknown. During the same period patient was treated with ZANTAC, SERTRALINE, EFFORTIL. Patient was hospitalized. Patient recovered.